So-Young International reports Q1 revenue decline, shares edge lower

Published 16/05/2025, 12:06
So-Young International reports Q1 revenue decline, shares edge lower

BEIJING - On Friday, So-Young International Inc. (NASDAQ:SY), China’s leading aesthetic treatment platform, reported a decline in first quarter revenue and widening losses as it continues to invest in its offline aesthetic center business.

The company’s shares edged 0.12% lower in pre-market trading following the earnings release.

The company reported revenue of RMB297.3 million ($41.0 million) for Q1 2025, down 6.6% year-over-year and at the high end of its previous guidance range. Non-GAAP net loss attributable to So-Young widened to RMB31.5 million ($4.3 million), compared to non-GAAP net income of RMB4.1 million in Q1 2024.

So-Young’s aesthetic treatment services revenue surged 551.4% YoY to RMB98.8 million, driven by the expansion of its branded aesthetic centers. However, this was offset by a 34.1% decline in information and reservation services revenue to RMB142.9 million.

"Our branded aesthetic centers continue to generate strong growth momentum, achieving triple-digit year-over-year revenue growth," said Xing Jin, Co-Founder and CEO of So-Young. "We remain focused on expanding the density of our aesthetic centers to deliver high-quality, cost-effective, and reliable medical aesthetic solutions to more consumers."

For Q2 2025, So-Young expects aesthetic treatment services revenue between RMB120.0-140.0 million, representing 337.3% to 410.1% YoY growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.